Biohope Shines at SET2024 Congress in Bilbao
Following the recent Congress of the Spanish Society of Transplantation (SET) in Bilbao, the organization has published the latest edition of SETnews. This issue summarizes the scientific sessions of the 8th SET Congress 2024, highlighting a key session on Saturday, May 11th dedicated to “Measuring Non-Adherence to Immunosuppressive Treatment and New Predictive Options.”
A notable presentation during this session was on the Immunobiogram (IMBG), a product developed by Biohope. Titled “Evaluation of Pharmacodynamic Response to Immunosuppressive Therapy in Transplant: IMBG, Evidence, and Applications,” it was delivered by Dr. Julio Pascual, Medical Director at the University Hospital 12 de Octubre. The roundtable discussion was moderated by renowned experts in the field: Dr. Manuel Muro Amador, Head of Immunology Service at H.C.U. Virgen Arrixaca (Murcia), and Dr. Marta Crespo Barrio, Head of Renal Transplant Section at Hospital del Mar (Barcelona).
The SETnews bulletin concludes with a powerful statement on the potential impact of the Immunobiogram: “The Immunobiogram could revolutionize this field by enabling the personalization of immunosuppressive treatment, with data already showing the relationship between pre-transplant sensitivity to each drug and the development of inflammation and/or rejection.”
You can see the complete bulletin in this link (only available in Spanish).
